Alexander Lesokhin, MD, on the Potential of Immunotherapy for Myeloma - Cancer Therapy Advisor

Alexander Lesokhin, MD, on the Potential of Immunotherapy for Myeloma

Chapter 1

What other research is promising, and where do you expect myeloma research to be in 5 years?

In this segment, Dr Lesokhin discusses new and emerging classes of drugs likely to transform treatment for patients with myeloma.

Chapter 2

PD-1 inhibition is noted as very promising for myeloma, though clinical trials haven’t shown a promising ORR. Why do you think this is?

In this segment, Dr Lesokhin discusses the potential of checkpoint inhibition for multiple myeloma.

Chapter 4

What potential does CAR-T cell therapy have in myeloma?

In this segment, Dr Lesokhin discusses how CAR-T cell therapy may be used in patients with multiple myeloma.